Target Name: GPR22
NCBI ID: G2845
Other Name(s): G-protein coupled receptor 22 | G protein-coupled receptor 22 | probable G-protein coupled receptor 22 | GPR22_HUMAN

GPR22: A Potential Drug Target and Biomarker for Many Diseases

G-protein coupled receptor 22 (GPR22) is a protein that is expressed in many different tissues throughout the body. It is a member of the G-protein coupled receptor family, which is a large superfamily of transmembrane proteins that play an important role in cellular signaling. GPR22 is characterized by its unique structure, which consists of a long extracellular domain, a short intracellular domain, and a short catalytic domain.

One of the key functions of GPR22 is its role in cell signaling. GPR22 is involved in a wide range of signaling pathways, including the regulation of pain, inflammation, and neurotransmitter signaling. It is also involved in the regulation of cell survival and proliferation, as well as the regulation of cell adhesion.

GPR22 is a potential drug target for a variety of diseases. For example, GPR22 has been shown to be involved in the regulation of pain, and is thought to play a role in the development of chronic pain. It is also involved in the regulation of inflammation, and has been shown to play a role in the regulation of autoimmune diseases. In addition, GPR22 is involved in the regulation of neurotransmitter signaling, and is thought to play a role in the treatment of neurodegenerative diseases.

Another potential application of GPR22 is as a biomarker for disease diagnosis and monitoring. GPR22 is expressed in many different tissues and cells, and its expression can be affected by a wide range of factors, including disease status, drug treatment, and environmental conditions. This makes GPR22 an attractive candidate for use as a biomarker for a variety of diseases. For example, GPR22 expression has been shown to be elevated in a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. It is also thought to be involved in the regulation of pain, and its expression has been shown to be elevated in individuals with chronic pain.

In conclusion, GPR22 is a protein that is involved in a wide range of cell signaling pathways. It is a potential drug target for a variety of diseases, including pain, inflammation, and neurotransmitter signaling. Its unique structure and broad range of functions make it an attractive candidate for use as a biomarker in a variety of diseases. Further research is needed to fully understand the role of GPR22 in cell signaling and its potential as a drug and biomarker.

Protein Name: G Protein-coupled Receptor 22

Functions: Orphan G-protein coupled receptor. Seems to act through a G(i)/G(o) mediated pathway (PubMed:18539757). May be involved in ciliogenesis (By similarity)

More Common Targets

GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A | GPRC5B | GPRC5C | GPRC5D | GPRC5D-AS1 | GPRC6A | GPRIN1 | GPRIN2 | GPRIN3 | GPS, PLAT and transmembrane domain-containing protein | GPS1 | GPS2 | GPS2P1 | GPSM1 | GPSM2 | GPSM3 | GPT | GPT2 | GPX1 | GPX1P1 | GPX2 | GPX3 | GPX4 | GPX5 | GPX6 | GPX7 | GPX8 | GRAMD1A | GRAMD1B | GRAMD1C | GRAMD2A | GRAMD2B | GRAMD4 | GRAMD4P2 | GRAMD4P5 | GRAMD4P7 | Granzyme | GRAP | GRAP2 | GRAPL | GRAPL-AS1 | GRASLND | GRB10 | GRB14 | GRB2 | GRB7 | GREB1 | GREB1L | GREM1 | GREM1-AS1 | GREM2 | GREP1 | GRHL1 | GRHL2 | GRHL3 | GRHL3-AS1 | GRHPR | GRIA1 | GRIA2